<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03456947</url>
  </required_header>
  <id_info>
    <org_study_id>CWW-PRBL-2017</org_study_id>
    <nct_id>NCT03456947</nct_id>
  </id_info>
  <brief_title>Pregabalin Stabilize Cardiovascular Response to Intubation</brief_title>
  <official_title>Research of Pregabalin Stabilize Cardiovascular Response to Laryngoscopy and Tracheal Intubation of Patients Under General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate whether Pregabalin is safe and effective in
      stabilizing cardiovascular response to laryngoscopy and tracheal intubation of patients under
      general anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">June 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>heart rate</measure>
    <time_frame>heart rate 3 minutes after intubation</time_frame>
    <description>effect of 300mg pregabalin, 150mg pregabalin premedication versus control group on the heart rate due to laryngoscopy and tracheal intubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>baseline mean arterial blood pressure before drug administration, heart rate before intubation, heart rate after 0 minute, 1minute, 3minutes, 5 minutes, 7minutes, 10minutes after intubation and before skin incision</time_frame>
    <description>effect of 300mg pregabalin, 150mg pregabalin premedication versus control group on the Mean arterial blood pressure due to laryngoscopy and tracheal intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>systolic blood pressure</measure>
    <time_frame>baseline systolic blood pressure before drug administration, heart rate before intubation, heart rate after 0 minute, 1minute, 3minutes, 5 minutes, 7minutes, 10minutes after intubation and before skin incision</time_frame>
    <description>effect of 300mg pregabalin, 150mg pregabalin premedication versus control group on the systolic blood pressure due to laryngoscopy and tracheal intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diastolic blood pressure</measure>
    <time_frame>baseline diastolic blood pressure before drug administration, heart rate before intubation, heart rate after 0 minute, 1minute, 3minutes, 5 minutes, 7minutes, 10minutes after intubation and before skin incision</time_frame>
    <description>effect of 300mg pregabalin, 150mg pregabalin premedication versus control group on the diastolic blood pressure due to laryngoscopy and tracheal intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ramsay score</measure>
    <time_frame>baseline Ramsay score before drug administration and Ramsay score before intubation</time_frame>
    <description>Ramsay score of 300mg pregabalin, 150mg pregabalin premedication versus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of all clinical adverse events</measure>
    <time_frame>1hour after surgery</time_frame>
    <description>The occurrence of dizziness, nausea, vomit and allergy</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Effect of Laryngoscopy and Tracheal Intubation</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>the patients receive routine preoperative preparation without having Pregabalin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregabalin150mg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the patients receive 150mg pregabalin 60 minutes prior to the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregabalin300mg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the patients receive 300mg pregabalin 60 minutes prior to the surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>the patients receive 150mg or 300mg pregabalin 60 minutes prior to the surgery</description>
    <arm_group_label>Pregabalin150mg group</arm_group_label>
    <arm_group_label>Pregabalin300mg group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists(ASA) grade I and II scheduled for elective
             surgery

        Exclusion Criteria:

          -  patient refusal.

          -  patients with serious chronic kidney, liver, lungs, or cardiovascular diseases.

          -  allergy to any of the study medications.

          -  patients taking sedation or antihypertensive medications.

          -  suspected difficult intubation or intubation time more than 22s.

          -  pregnant or breastfeeding women.

          -  BMI&gt;30.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Chen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Hospital Qinpu Branch, Fudan University, Shanghai</affiliation>
  </overall_official>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

